Sign up to save your podcasts
Or
Share Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain
During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.
View all episodes
By BMO
4.6
55 ratings
During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.
More shows like Markets Plus
View all
WSJ What’s News
4,310 Listeners
Bloomberg Surveillance
1,191 Listeners
Bloomberg Intelligence
400 Listeners
Insights Now
93 Listeners
Masters in Business
2,189 Listeners
Goldman Sachs Exchanges
982 Listeners
Odd Lots
1,759 Listeners
The Meb Faber Show - Better Investing
932 Listeners
The Bid
250 Listeners
Thoughts on the Market
1,268 Listeners
At Any Rate
77 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
8,775 Listeners
The Memo by Howard Marks
399 Listeners
Bloomberg Daybreak: US Edition
51 Listeners
Goldman Sachs The Markets
72 Listeners